Osteoarthritis in People with Multiple Sclerosis: A Systematic Review and Meta-Analysis
Authors:
- Vasileios GiannopapasVasileios Giannopapas
- Vassiliki SmyrniVSVassiliki Smyrni
- Dimitrios K. KitsosDKDimitrios K. Kitsos
- Sophia StasiSSSophia Stasi
- Athanasios K. ChasiotisACAthanasios K. Chasiotis
- Christos MoschovosCMChristos Moschovos
- Georgia PapagiannopoulouGPGeorgia Papagiannopoulou
- Konstantina StavrogianniKSKonstantina Stavrogianni
- Maria KosmidouMKMaria Kosmidou
- Daphne BakalidouDBDaphne Bakalidou
- John S. TzartosJTJohn S. Tzartos
- Georgios TsivgoulisGeorgios Tsivgoulis
Open Access
- 24 August 2024
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 5015
Abstract
Background: Arthritis, particularly osteoarthritis (OA), is a common synovial condition observed in individuals with multiple sclerosis (MS). Despite its high prevalence and significant impact on the quality of life of MS individuals, there is a gap in the current literature regarding the prevalence of OA in this population and its relation to MS pathology. This systematic review and meta-analysis aimed to estimate the prevalence of OA in the MS population and explore potential associations with demographic and MS-specific characteristics. Methods: Adhering to PRISMA guidelines, a systematic search of the MEDLINE PubMed, Scopus and Google Scholar databases was conducted. Results: Fifteen studies were included in the systematic review and meta-analysis. The aggregated prevalence of OA in the MS population was 27% (95% CI: 15–40%), with substantial heterogeneity (I2 = 99.9%). Sensitivity analysis, excluding one study, showed a prevalence of 21% (95% CI: 16–28%). The risk ratio of OA in MS versus controls was 1.07 (95% CI: 0.84–1.37), indicating no significant difference. Meta-regression revealed no associations between OA prevalence and age or disease duration in MS patients. Conclusions: This study reports a 21–27% prevalence of OA in people with MS. Understanding the implications of OA in pain and mobility domains, as well as the challenges in distinguishing OA symptoms from MS manifestations, underscores the need for further research to elucidate the pathophysiological mechanisms and interactions between these conditions. Additional studies are warranted to enhance clinical management and improve outcomes for individuals with MS and co-existing OA.Keywords
This publication has 54 references indexed in Scilit:
- Reliability and concurrent validity of 30-s and 5-time sit-to-stand tests in older adults with knee osteoarthritisClinical Rheumatology, 2024
- Functional manifestations of early knee osteoarthritis: a systematic review and meta-analysisClinical Rheumatology, 2022
- Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosisJournal of Neurology, 2020
- Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosisJournal of Neurology, 2020
- Comorbidities contribute substantially to the severity of common multiple sclerosis symptomsJournal of Neurology, 2020
- Alterations in peripheral T cell and B cell subsets in patients with osteoarthritisClinical Rheumatology, 2019
- Meta-Analysis and SubgroupsPrevention Science, 2013
- Impact of diabetes and its treatments on skeletal diseasesFrontiers of Medicine, 2013
- Osteoarthritis☆Advanced Drug Delivery Reviews, 2006
- The influence of walking speed on gait parameters in healthy people and in patients with osteoarthritisKnee Surgery, Sports Traumatology, Arthroscopy, 2005